Dietary supplementation of fructooligosaccharides reduces hepatic steatosis associated with insulin resistance in obese zucker rats

Functional Foods in Health and Disease

Volumn 1, Issue 5, 2011, Pages 199-213

  Kaume, Lydia ^a   Gilbert, William ^a   Gadang, Vidya ^a   Devareddy, Latha ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Dietary fiber; Fructooligosaccharide; Hepatosteatosis; Liver lipids; Non alcoholic fatty liver disease (NAFLD); Zucker

Indexed keywords

EID: 84892977351     PISSN: 23787007     EISSN: 21603855     Source Type: Journal    
DOI: 10.31989/ffhd.v1i5.130     Document Type: Article

References (45)

1. Kelly T, Yang W, Chen CS, Reynolds K, He J: Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008, 32:1431-1437.
2. National Center for Health Statistics. Prevalence of Overweight and Obesity Among Adults:United States, 2003-2004. [http://www.cdc.gov/nchs/products/pubs/pubd/hestats/overweight/overwght_adult_03.htm].
3. Fava F, Lovegrove JA, Tuohy KM, Gibson GR: The potential role of the intestinal gut microbiota in obesity and the metabolic syndrome. Food Science & Technology Bulletin: Functional Foods 2009, 5:71-92.
4. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 2000, 106:473-481.
5. Torra IP, Chinetti G, Duval C, Fruchart JC, Staels B: Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice. Curr Opin Lipidol 2001, 12:245.
6. Jenkins DJA, Kendall CWC, McKeown-Eyssen G, Josse RG, Silverberg J, Booth GL, Vidgen E, Josse AR, Nguyen TH, Corrigan S: Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA 2008, 300:2742-2753.
7. Sung H, Choi Y, Cho S, Yun J: Fructooligosaccharides alter profiles of fecal short-chain fatty acids and bile acids in rats. Food Sc Biotech 2006, 15:51-56.
8. Swanson KS, Grieshop CM, Flickinger EA, Bauer LL, Chow JM, Wolf BW, Garleb KA, Fahey GC: Fructooligosaccharides and Lactobacillus acidophilus Modify Gut Microbial Populations, Total Tract Nutrient Digestibilities and Fecal Protein Catabolite Concentrations in Healthy Adult Dogs 1. J Nutr 2002, 132:3721-3731.
9. Bornet FRJ, Brouns F, Tashiro Y, Duvillier V: Nutritional aspects of short-chain fructooligosaccharides: natural occurrence, chemistry, physiology and health implications. Dig Liv Dis 2002, 34:111-120.
10. Alles MS, De Roos NM, Bakx JC, Van de Lisdonk E, Zock PL, Hautvast J: Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am J Clin Nutr 1999, 69:64-69.
11. Delzenne NM, Kok N, Fiordaliso MF, Deboyser DM, Goethals FM, Roberfroid MB: Dietary fructooligosaccharides modify lipid metabolism in rats. Am J Clin Nutr 1993, 57:820-820.
12. Frederique R, Swanson KS, Belsito KR, Vester BM, Wagner A, Istasse L, Diez M: Short-Chain Fructooligosaccharides Influence Insulin Sensitivity and Gene Expression of Fat Tissue in Obese Dogs. J Nutr 2008, 138:1712-1718.
13. Kok NN, Taper HS, Delzenne NM: Oligofructose modulates lipid metabolism alterations induced by a fat-rich diet in rats. J Appl Toxicol 1998, 18:.
14. Jurgoński A, Juśkiewicz J, Zduńczyk Z: Comparative effects of different dietary levels of cellulose and fructooligosaccharides on fermenta-tive processes in the caecum of rats. Journal of Animal and Feed Sciences 2008, 17:88-99.
15. Delzenne NM, Kok N: Effects of fructans-type prebiotics on lipid metabolism. Am J Clin Nutr 2001, 73:456S.
16. Cani PD, Neyrinck AM, Maton N, Delzenne NM: Oligofructose Promotes Satiety in Rats Fed a High-Fat Diet: Involvement of Glucagon-Like Peptide-1* &ast. Obesity 2005, 13:1000-1007.
17. Ditschuneit HH, Flechtner-Mors M, Johnson TD, Adler G: Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. Am J Clin Nutr 1999, 69:198.
18. Williams CM, Jackson KG: Inulin and oligofructose: effects on lipid metabolism from human studies. Br J Nutr 2007, 87:261-264.
19. Folch J, Lees M, Stanley G: A simple method for total lipid-extraction and purification. J Biol Chem 1957, 226:497-509.
20. Searcy RL, Bergquist LM, Jung RC: Rapid ultramicro estimation of serum total cholesterol. The Journal of Lipid Research 1960, 1:349-351.
21. Schiffrin EJ, Blum S: Interactions between the microbiota and the intestinal mucosa. Eur J Clin Nutr 2002, 56 Suppl 3:S60-4.
22. Losada MA, Olleros T: Towards a healthier diet for the colon: the influence of fructooligosaccharides and lactobacilli on intestinal health. Nutr Res 2002, 22:71-84.
23. Devareddy L, Khalil AD, Korlagunta K, Hooshmand S, Bellmer DD, Bahram HA: The effects of fructo-oligosaccharides in combination with soy protein on bone in osteopenic ovariectomized rats. The Journal of The North American Menopause Society 2006, 13:692-699.
24. Ohta A, Ohtsuki M, Baba S, Takizawa T, Adachi T, Kimura S: Effects of fructooligosaccharides on the absorption of iron, calcium and magnesium in iron-deficient anemic rats. J Nutr Sci Vitaminol 1995, 41:281-291.
25. Oku T, Tokunaga T, Hosoya N: Nondigestibility of a new sweetener, "Neosugar," in the rat. J Nutr 1984, 114:1574-1581.
26. Molis C, Flourie B, Ouarne F, Gailing MF, Lartigue S, Guibert A, Bornet F, Galmiche JP: Digestion, excretion, and energy value of fructooligosaccharides in healthy humans. Am J Clin Nutr 1996, 64:324-328.
27. Giacco R, Clemente G, Luongo D, Lasorella G, Fiume I, Brouns F, Bornet F, Patti L, Cipriano P, Rivellese AA: Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Ciin Nutr 2004, 23:331-340.
28. Daubioul C, Rousseau N, Demeure R, Gallez B, Taper H, Declerck B, Delzenne N: Dietary Fructans, but Not Cellulose, Decrease Triglyceride Accumulation in the Liver of Obese Zucker fa/fa Rats 1. J Nutr 2002, 132:967-973.
29. Daubioul CA, Taper HS, De Wispelaere LD, Delzenne NM: Dietary Oligofructose Lessens Hepatic Steatosis, but Does Not Prevent Hypertriglyceridemia in Obese Zucker Rats 1. J Nutr 2000, 130:1314-1319.
30. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N: Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999, 107:450-455.
31. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C: NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2003, 35:373-379.
32. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN: Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001, 120:1183-1192.
33. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI: Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004, 279:32345-32359.
34. Korenblat KM, Fabbrini E, Mohammed BS, Klein S: Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008, 134:1369-1375.
35. Agheli N, Kabir M, Berni-Canani S, Petitjean E, Boussairi A, Luo J, Bornet F, Slama G, Rizkalla SW: Plasma lipids and fatty acid synthase activity are regulated by short-chain fructo-oligosaccharides in sucrose-fed insulin-resistant rats. J Nutr 1998, 128:1283.
36. Katsurada A, Iritani N, FUKUDA H, Matsumura Y, Nishimoto N, Noguchi T, Tanaka T: Effects of nutrients and hormones on transcriptional and post‐transcriptional regulation of fatty acid synthase in rat liver. Eur J Biochem 1990, 190:427-433.
37. Beylot M: Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr 2005, 93:163-168.
38. Lucas EA, Lightfoot SA, Hammond LJ, Devareddy L, Khalil DA, Daggy BP, Smith BJ, Westcott N, Mocanu V, Soung DY: Flaxseed reduces plasma cholesterol and atherosclerotic lesion formation in ovariectomized Golden Syrian hamsters. Atherosclerosis 2004, 173:223-229.
39. Fiordaliso M, Kok N, Desager JP, Goethals F, Deboyser D, Roberfroid M, Delzenne N: Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats. Lipids 1995, 30:163-167.
40. Trautwein EA, Rieckhoff D, Erbersdobler HF: Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamsters. J Nutr 1998, 128:1937-1943.
41. Busserolles J, Gueux E, Rock E, Demigne C, Mazur A, Rayssiguier Y: Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats. J Nutr 2003, 133:1903-1908.
42. Forcheron F, Beylot M: Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans. Metab Clin Exp 2007, 56:1093-1098.
43. Fukuda N, Azain MJ, Ontko JA: Altered hepatic metabolism of free fatty acids underlying hypersecretion of very low density lipoproteins in the genetically obese Zucker rats. J Biol Chem 1982, 257:14066-14072.
44. Chinetti G, Fruchart JC, Staels B: Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflammation Res 2000, 49:497-505.
45. Zhou XR, Sun CH, Liu JR, Zhao D: Dietary conjugated linoleic acid increases PPAR [gamma] gene expression in adipose tissue of obese rat, and improves insulin resistance. Growth Hormone & IGF Research 2008, 18:361-368.